RT Journal Article
SR Electronic
T1 Viral loads observed under competing strain dynamics
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.27.21261224
DO 10.1101/2021.07.27.21261224
A1 James A. Hay
A1 Lee Kennedy-Shaffer
A1 Michael J. Mina
YR 2021
UL http://medrxiv.org/content/early/2021/07/30/2021.07.27.21261224.abstract
AB A plausible mechanism for the increased transmissibility of SARS-CoV-2 variants of concern (VOCs) results from VOC infections causing higher viral loads in infected hosts. However, investigating this hypothesis using routine RT-qPCR testing data is challenging because the population-distribution of viral loads changes depending on the epidemic growth rate; lower cycle threshold (Ct) values for a VOC lineage may simply reflect increasing incidence relative to preexisting lineages. To understand the extent to which viral loads observed under routine surveillance systems reflect viral kinetics or population dynamics, we used a mathematical model of competing strain dynamics and simulated Ct values for variants with different viral kinetics. We found that comparisons of Ct values obtained under random cross-sectional surveillance were highly biased unless samples were obtained at times when the variants had comparable growth rates. Conversely, comparing Ct values from symptom-based testing was largely unaffected by epidemic dynamics, and accounting for the time between symptom onset and sample collection date further reduced the risk of statistical errors. Finally, we show how a single cross-sectional sample of Ct values can be used to jointly estimate differences in viral kinetics and epidemic growth rates between variants. Epidemic dynamics should be accounted for when investigating strain-specific viral kinetics using virologic surveillance data, and findings should be corroborated with longitudinal viral kinetics studies.Competing Interest StatementMJM is an advisor for Detect, LivePerson and COVID Signals. JAH and LKS declare no competing interests.Funding StatementThis work was supported by the US National Institutes of Health Director's Early Independence Award DP5-OD028145 (MJM and JAH).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicable. All data used in this study were generated through computer simulations.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll code to perform the analyses and generate the figures presented in this article are available under the GNU General Public License version 3 at https://github.com/jameshay218/variant_viral_loads. https://github.com/jameshay218/variant_viral_loads